PRESS RELEASE published on 06/03/2026 at 19:54, 5 months 4 days ago Inside Information / Other news releases Median Technologies successfully completes €50 million capital increase without shareholders' preferential subscription rights. Funds to deploy eyonis® LCS in U.S. and Europe and expand clinical indications Investment Capital Increase Median Technologies Eyonis® LCS Clinical Indications
BRIEF published on 05/21/2026 at 17:50, 5 months 17 days ago Median Technologies publie les documents de l'assemblée générale des actionnaires Droit De Vote Euronext Croissance Assemblée Générale Des Actionnaires Technologies Médianes Disponibilité Des Documents
BRIEF published on 05/21/2026 at 17:50, 5 months 17 days ago Median Technologies Publishes Shareholder Meeting Documents Voting Rights Shareholders’ Meeting Euronext Growth Median Technologies Documents Availability
PRESS RELEASE published on 05/21/2026 at 17:45, 5 months 17 days ago Terms of availability of the information and the report on corporate governance Median Technologies releases preparatory documents for the Annual Shareholders’ Meeting on June 10, 2026. Shareholders can access documents on the company's website Shareholders General Meeting Annual Shareholders’ Meeting Preparatory Documents Median Technologies
BRIEF published on 03/30/2026 at 15:19, 7 months 8 days ago Median Technologies obtient la certification ISO 13485:2016 ISO 13485:2016 Normes Réglementaires Logiciel Basé Sur L'IA Solutions En Oncologie Eyonis®
BRIEF published on 03/30/2026 at 15:19, 7 months 8 days ago Median Technologies Achieves ISO 13485:2016 Certification ISO 13485:2016 Regulatory Standards Oncology Solutions Eyonis® AI-based SaMD
PRESS RELEASE published on 03/30/2026 at 15:14, 7 months 8 days ago Inside Information / Other news releases Median Technologies achieves ISO 13485:2016 certification for eyonis® Medical Device Quality Management System, reinforcing commitment to safe and reliable oncology solutions Median Technologies AI-based Software Oncology Solutions ISO 13485:2016 Certification Eyonis Medical Device
BRIEF published on 02/12/2026 at 22:10, 8 months 23 days ago Median Technologies and Tempus Partner to Expand Lung Cancer Screening in the U.S. FDA Clearance Median Technologies Lung Cancer Screening Eyonis® LCS Tempus AI
BRIEF published on 02/12/2026 at 22:10, 8 months 23 days ago Median Technologies et Tempus s'associent pour étendre le dépistage du cancer du poumon aux États-Unis. Autorisation De La FDA Technologies Médianes Dépistage Du Cancer Du Poumon Eyonis® LCS Tempus IA
PRESS RELEASE published on 02/12/2026 at 22:05, 8 months 23 days ago Informations privilégiées / Autres communiqués Median Technologies collabore avec Tempus pour distribuer le logiciel eyonis® LCS aux États-Unis, suite à l'obtention de l'autorisation FDA 510(k) pour le dépistage du cancer du poumon via Tempus Pixel Median Technologies Eyonis® LCS Tempus FDA 510(k) Dépistage Cancer
Published on 11/06/2026 at 22:15, 1 day 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 21 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 21 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 21 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 20 hours 27 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 1 day 13 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 1 day 13 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 1 day 14 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 day 15 hours ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 19:06, 1 day 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 1 day 14 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 1 day 15 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 1 day 15 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
